
About 85% of all instances of lung cancer are non-small cell lung cancer (NSCLC), making it the most common kind of the disease. It happens when aberrant cells proliferate in the lungs and cause tumors to grow. Compared to small cell lung cancer (SCLC), non-small cell lung cancer (NSCLC) is typically less aggressive and grows and spreads more slowly.
There are many types of NSCLC, including-
Timely treatment of Non-Small Cell Lung Cancer (NSCLC) is essential for several reasons:
Respiratory Symptoms
Chest Symptoms
General Symptoms
Causes
Risk Factors
Through the use of immunotherapies, targeted medicines, and innovative research, Turkey has achieved notable progress in the treatment of non-small cell lung cancer (NSCLC). Gene mutations are treated with protein inhibitors (TKIs), and other NSCLC instances benefit from immune checkpoint medications. Recent research has been devoted to combining immunotherapy with targeted treatments to improve efficacy and reduce resistance.
There are a few things you can do to lower your risk of developing Non-Small Cell Lung Cancer (NSCLC), particularly of the bladder, even if it is not always preventable:
Treatment options for NSCLC differ based on the type and stage of the disease and the patient's overall health. The following are a few current treatments:
Lobectomy: Elimination of a lung lobe. The most popular procedure for NSCLC in its early stages is this one.
Pneumonectomy: Removal of a lung in its whole. If the cancer is in an area of the lung where the entire organ needs to be removed, this procedure might be carried out.
Wedge Resection: This removes a little lung section with the tumor.
Segmentectomy: This is the Removal of a more prominent lung segment but not the entire lobe. Usually, this is applied to individuals with lung impairment or early-stage cancer.
Radiation Therapy: Treatments using high-energy rays to target cancer cells and reduce tumour size are known as radiation therapy. It may be used in combination with chemotherapy for Non-Small Cell Lung Cancer (NSCLC).
Targeted Therapy : Medication designed for particular forms of lung cancer is used in this treatment. Targeted therapy can locate and target specific cancer cells without endangering healthy cells.
Cost Start From USD 7500 - USD 12000Explore Options
Immunotherapy : This is typically advised for late-stage lung cancer, notably Stage IV NSCLC, as it triggers your body's immune system to target and eliminate cancer cells.
Cost Start From USD 7420 - USD 42500Explore Options
Chemotherapy : It uses medications that target lung cancer. It is among the most widely used therapies for NSCLC. Chemotherapy may be prescribed by your oncologist alone or in conjunction with other treatments.
Cost Start From USD 7420 - USD 30000Explore Options
Clinical Evaluation
Imaging Studies
Biopsy
Laboratory Tests
MediRehab (a chain of Rehab centres, part of MediGence) provides comprehensive rehabilitation services to support patients through Teleconsulations and online therapy sessions.
Lifestyle changes and modification
While lifestyle modifications like stress reduction, yoga, and meditation improve general well-being, dietary changes involving high-fiber meals, lean meats, and supplements boost nutrition. Long-term health is further enhanced by abstaining from alcohol and eating a balanced diet.
Speech and Swallowing Therapy
Patients with NSCLC may have trouble speaking or swallowing if the disease affects the mouth, throat, or digestive system. Speech therapists can help patients regain clarity in their speech and enhance their swallowing function.
Monitoring and follow-up
Schedule regular follow-up appointments with the oncologist to address complications, monitor recovery, and detect any signs of recurrence.
Depending on the circumstances, your doctor might recommend medication to help manage your symptoms and complement the course of treatment.









Istanbul, Turkey
Medical Park Fatih Hospital located in Istanbul, Turkey is accredited by JCI. Also listed below are some of the most prominent infrastructural details:

Istanbul, Turkey
Biruni University Hospital started to serve in 2016. It is a full-fledged multi-specialty healthcare facility, situated in Istanbul, Turkey. The hospital is well-known for its outstanding medical care standards, and it has acquired numerous certificates from international quality organizations. It is a renowned & well-established healthcare facility that provides cutting-edge diagnostic and treatment approaches. They have a team of highly skilled doctors and surgeons on call 24 hours a day, seven days a week to deliver the best medical care possible.
The hospital has various medical departments such as Cardiology, Neurology, Urology, Rheumatology, Pediatrics, General Medicine and Surgery, Gastroenterology, etc. Popular treatments conducted at the hospital are Pediatric Neurology, Cardiac Stenting, Balloon Angioplasty, Bypass surgery, plastic surgery procedures like Hair transplant, & Botox injections, and many more. The hospital is known for its most valuable service i.e. service to human health. Hospital management & professionals define their service concept with the significance attached to the belief. The management is concerned with both medical statistics and, above all, the satisfaction of the patients. Patients from other countries are well looked after. The hospital offers international patients a relaxing and secure environment in terms of psychology, comfort, and health.
The hospital's primary purpose is to provide world-class patient-centered health care through our highly responsible team who can produce information and use it appropriately. With its university-based scientific infrastructure and competent health care, the hospital's management has long-term plans for it, with a desire to be an innovative and leading health institution that is regarded as a reference in the country and around the world. Several value-added services and quality policies are available at the facility. To mention a few, the hospital is open to development and technology, continuously measuring and improving, training qualified health professionals, caring about patient and employee satisfaction, and becoming mobilized to bring an environment of reliable diagnosis, treatment, and care to the majority of the society.

Ankara, Turkey
Opinion & Option
We submit the most accurate opinion and options from one or more countries for your review
Consult Privately
Consult with a certified specialist privately on our telemedicine platform even before you decide to travel
Logistics
We handle flights, visas, transfers, and accommodation—so you can focus on your health.
Recovery
Our In-house rehabilitation service packages to better your recovery and treatment outcome
In Turkey, recovery times following therapy for non-small cell lung cancer (NSCLC) vary depending on the type of treatment, the features of the tumor, and the patient's health. Recovery from other therapies, like as chemotherapy or radiation, can take anything from a few weeks to several months, whereas recovery from surgery may take between 6 to 12 weeks.
In Turkey, it is customary practice to get a second opinion. A lot of hospitals and oncologists are willing to assess cases and offer second opinions on treatment strategies. One can:
Yes, MediGence offers a wide range of assistance to patients from other countries seeking treatment for non-small cell lung cancer. The majority of large hospitals offer specialised departments for international patients that help with accommodations, airport transfers, visa arrangements, and language translation. To ensure that overseas patients have a seamless and hassle-free experience throughout their treatment journey, these departments also assist with financial information, appointment scheduling, and post-treatment care.
To minimise side effects and keep an eye out for recurrence, post-treatment care for non-small cell lung cancer (NSCLC) in Turkey involves routine follow-ups with oncology specialists. Individualised rehabilitation plans and lifestyle counseling are provided to patients in order to improve their general health and speed of recovery.
Yes, even after a successful course of treatment, non-small cell lung cancer (NSCLC) might return. The type of treatment received, the patient's response to the treatment, and the stage of the cancer at diagnosis all affect the chance of recurrence.
In Turkey, the prognosis for individuals with non-small cell lung cancer (NSCLC) varies according to the cancer stage at diagnosis, general health, and response to treatment. Early identification and sophisticated treatment options available in Turkey can enhance survival chances.
About 41,000 new instances of lung cancer were reported in 2020, making it the most common cancer in Turkey. About 80% of these cases are non-small cell lung cancer (NSCLC), which makes it a prevalent cancer type in the nation.
Turkey is a cost-effective choice for those seeking treatment because it provides top-notch medical care at affordable costs compared to several Western nations.
Yes, Turkey's healthcare system accepts patients from abroad and provides excellent NSCLS treatments at many clinics and hospitals.
Yes, many Turkish hospitals offer in-person and online consultations to foreign patients who want a second opinion.